Events & conferences in the Life Sciences industry

Congress Center Basel
Basel Switzerland

5th Annual MedTech & Digital Health Forum to take place on the 25th of September at the Congress Center Basel one day before our 17th Annual BEF Forum. The programme is designed to highlight the latest industry developments and showcase emerging and innovative technology companies seeking finance and partnerships. The delegates are comprised of Healthcare, MedTech, Healthcare IT, and Digital Health companies as well as consultants, bankers and corporate & financial investors. We expect over 250 delegates and 25 presenting companies.

Boston Marriott Copley Place
Boston, USA

The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels. The conference helps facilitate face to face meetings between companies and investors based on a common fit (indication, technology & stage of development) which promotes compelling conversations, facilitating the development of qualified investor to entrepreneur relationships. The RESI Conference also serves as an excellent opportunity for large pharma/ medtech companies and service providers to connect with attending companies and investors representing their portfolio companies.

Sheraton Boston Hotel
Boston, MA, USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2016, BioPharm America attracted 850+ delegates from over 525 companies who participated in 2,350+ scheduled one-to-one meetings.

Congress Center Basel
Basel Switzerland

17th Annual Biotech in Europe Forum for Global Partnering & Investment to take place on the 26th – 27th of September at the Congress Center Basel. The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. The Forum draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect over 600+ delegates and 100+ presenting companies. The Meeting will provide a number of networking opportunities via our online 1-2-1 meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We expect more than 1500 meetings to take place throughout the 2 days.

Hilton Zurich Airport Hotel
Zurich Switzerland

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

The Wyss Center at Campus Biotech
Geneva Switzerland

Entering its fourth year, the International Neurotech Investing and Partnering Conference is the premier forum for the neurotechnology industry. Spanning pharmaceuticals, medical devices, software, and diagnostics for use in neuroscience, this global forum gathers investors, executives, entrepreneurs, and scientists to shape the future of their organizations and the field. This market-defining event, organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, features keynotes on the state of the neurotech industry worldwide, cutting edge company presentations, leading translational research projects, and panel discussions on a comprehensive selection of neurobiology topics.

Mission Bay Conference Center
San Francisco USA

The SynBioBeta SF synthetic biology conference is back for its sixth year with more than 16 sessions, 60 speakers, and 30 exhibitors —the movers and shakers of an industry that’s driving technology and business. Key themes this year include biomaterials and consumer products, cell factories for biopharmaceuticals, big data and artificial intelligence meet biology, and innovations for ocean sustainability. And, you won’t want to miss a fireside chat with pioneers George Church and Vinod Khosla.

The Royal Sonesta Boston
Boston USA

McDermott Will & Emery's 6th Annual Life Sciences Dealmaking Symposium will focus on the opportunities and challenges for those investing and operating in the multibillion dollar life sciences industry. Our seasoned panel of dealmakers, industry executives and thought leaders will provide practical insights and guidance into successfully navigating the dynamic and burgeoning deal landscape in the biotech, pharmaceutical, medtech and digital health industry.

Munich Germany

C5’s Life Sciences IP Summit returns for its fourth year offering a comprehensive programme that is bursting with variety, topical relevance and focussed discussion on the issues that really matter. IP Summit 2017 will bring together the top Life Sciences IP experts from across Europe and a truly unique learning and networking experience. Join with colleagues from across Europe to customise your learning and network in a prestigious and interactive environment! The Life Science IP Summit programme is in progress for 2017! Request the draft agenda here and be the first to receive an email notification when the full agenda is available. Biotech Gate is partnering with this Conference. Get an extra 15% off when you use D15-999-BTG18 when registering.

Pacifico Yokohama
Yokohama Japan

Asia's premier partnering event for the global biotechnology that has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. Top business development, licensing, and alliance management professionals, R&D personnel, and biotech company executives from around the world will gather in Yokohama in October 2017 for the 19th iteration of BioJapan. Over 900 organizations from around 30 countries are expected to participate in the event, to hold an anticipated 8,000 business meetings over the course of the three days.

Berlin Partner für Wirtschaft und Technologie
Berlin Germany

Organized by Fit for Health 2.0 in collaboration with Berlin Partner and the European IPR Helpdesk, the event will be tailored to executive representatives of high-tech and research-intensive SMEs of all health-related sectors, such as pharma, biotech, med-tech, therapeutics, diagnostics, e-health. You will be introduced to the principles of valuation and negotiation with equity investors in life sciences, followed by a case study in which the valuation of a drug in development and the negotiation of a fair licensing deal will be simulated.

Westin St. Francis Hotel
San Francisco, USA

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One PartneringTM meetings.

Park Inn by Radisson Toronto Airport West
Toronto Canada

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Sofitel Hotel
Melbourne Australia

Annual event that gives the opportunity to Life Science companies from Australia and around the world to present their business and technologies to investors.

Skyway Room 2, Adelaide Convention Centre
Adelaide Australia

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world. Know how to assess and calculate the value of a biotech company. Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Adelaide Convention Center
Adelaide Australia

The annual AusBiotech conference has brought together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally. AusBiotech is dedicated to consolidating this growth, and our 2017 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials and commercisalisation.

CityCube Berlin
Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.

The Landmark Hotel
London UK

The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, and the business models and transformation strategies that will be needed to survive and thrive in this new era of unprecedented disruption and uncertainty. Speakers include: Rod MacKenzie, Executive Vice President, Chief Development Officer, Pfizer; Bahija Jallal Executive Vice President, AstraZeneca; Head, MedImmune; Vivek Ramaswamy, Chief Executive Officer, Roivant Sciences. Biotechgate subscribers are entitled to a 10% discount, which can be activated by using the code BIOT10 when registering.

Ernst & Young
London United Kingdom

OBN, UK and Eurasanté, France, are delighted to announce the launch of BioSeed®, a joint venture event devised to provide a unique platform for early-stage Life Sciences companies, Technology Transfer Offices (TTO) and Universities throughout Europe seeking equity investment from Angels, High-Net-Worth individuals, specialist Crowd-Funders, and PE / VC funders genuinely interested in Seed and Series ‘A’ funding.

Sheraton Lisboa Hotel & Spa
Lisbon Portugal

Building on 15 years of success, Cambridge Healthtech Institute brings the popular Strategic Alliance Management Congress to Europe. The event will unite senior alliance management, business development, technology transfer and licensing professionals to network, discuss case studies, and share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of Alliance Management.

Hilton Zurich Airport Hotel
Zurich Switzerland

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Hilton Zurich Airport Hotel
Zurich Switzerland

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Hilton Zurich Airport Hotel
Zurich Switzerland

Be able to decide on the best deal type – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Strasbourg France

With an exclusive partnership with EBD Group, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the marketplace for pre-seed, seed and Series A investment in Life Sciences. More than 1,200 international leading actors of human and animal health from 30+ countries meet every year to: • Entail new partnerships • Source innovative and competitive early stage R&D projects • Facilitate the emergence of collaborative projects • Increase licensing opportunities BioFIT gathers big pharma, emerging biotech companies, TTOs, research institutions, academia, preclinical CROs and pre-seed/seed/Series A investors. Through a unique exchange framework, BioFIT combines: • Pre-qualified one-to-one meetings (partneringONE platform from EBD Group) • Conferences and roundtable discussions • Presentations of start-ups and licensing opportunities stemming from academia • An exhibition area • Informal networking evenings

JW Marriott Dubai
Dubai United Arab Emirates

Meetings International proudly announces the Global Meeting On Materials Science & Nanotechnology. With a theme of “Effect of smart material Science in our daily life and its advancement ". The conference provides a Global Platform for Materials Science, Ceramic, Metallurgy, Chemical, Pharma, Biotech, Medical and Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

Renaissance London Heathrow Hotel
London United Kingdom

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

QEII Centre
London UK

From Bio-Innovation to Health and Wealth Delivery in Tomorrow’s World Genesis 2017 will build on the previous 16 years of experience in assembling a forum where industry executives, investors, academic researchers, policymakers and the expert advisers can exchange and debate their collective insight in order to provide true thought leadership for the sector, themselves and their stakeholders. Our ability to investigate the biological processes linked to ill health is combining with our ability to collect, combine and interrogate ever increasing and complex data sets to enable researchers to generate innovate treatment hypotheses for better targeted and effective interventions. These interventions may be biochemical or mechanical and indeed in some cases preventative rather than therapeutic. The previous Genesis showcased and debated how innovative scientific, technology and business strategies were facilitating the transformation of knowledge into better outcomes for all stakeholders. Under the overarching theme of “From Bio-Innovation to Health and Wealth Delivery in Tomorrow’s World”, our 17th Annual Genesis Conference, will take place on Thursday 14 December 2017 in London. The event will again engage all the key elements for those active in R&D, finance, policy making and service provision across Life Sciences, Digital and Health Technology fields in creating a vision of where the sector is heading. Over 70 expert speakers and panellists will lead sessions discussing which approaches will deliver better outcomes for patients, investors and payers.

Marine's Memorial Club
San Francisco USA

Building on the success of our 2nd Annual Neuroscience BioPartnering & Investment Forum we are pleased to announce The Neuroscience & Technology Innovation Forum to take place at Marines' Memorial Club, San Francisco on the 7th of January 2018, a day before the JP Morgan meeting. The program will cover BioPartnering for CNS, with industry keynotes and panels on AD, PD, Neuropsychiatry and Pain Management . Moreover there are panels on innovation in NeuroTech covering banking, device, diagnostics and software. The target audience are buy and sell side analysts from investment banks and funds and partnering executives from pharma and medtech companies. We anticipate around 200 delegates and 20 company presentations by established and emerging companies. There are numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

New York, USA

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

Hyderabad India

The Fifteenth edition of BioAsia being organized by Federation of Asian Biotech Associations in partnership with Government of Telangana and Government of India aims to bring together the diverse stakeholders of life sciences namely the top scientists, researchers, innovative thinkers, policy makers, regulators, academia representatives , practitioners, students and companies from across the life science landscape. Also eminent scientists and expert speakers from various parts of the world will lead sessions, lectures and panel discussions. The conferences will be based upon the themes of translational research, biotech and Pharma research, medical devices and diagnostics, healthcare IT, drug discovery which are serving as a catalyst for the continued growth of India’s robust life sciences industry. BioAsia 2018 is set to emerge as a global forum for the exchange of ideas, academia-industry collaborations, technology transfer and early-stage innovations in the field of Life Sciences.

Amsterdam The Netherlands

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Grand Hyatt Tokyo
Tokyo, Japan

The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market.

New York USA

Following the success of the last year’s forum, we are pleased to announce the 3rd Annual Neuroscience BioPartnering & Investment Forum to take place on 20th of March at the New York Academy of Sciences. It will focus on key areas of neurodegenerative diseases and pain management with a mix of specialist panels and company presentations. The event is targeted at buy and sell side analysts from investment banks and funds and partnering executives from pharma. We anticipate over 200 delegates and more than 20 presentations by listed and private biotechnology companies seeking licensing & investment opportunities. The forum’s networking is boosted by the use of our usual online one-to-one meeting system with dedicated meeting facilities.

New York USA

This year again, following the success of the previous four editions, we are delighted to announce our 6th Annual Cancer BioPartnering & Investment Forum to take place on 21th of March at the New York Academy of Sciences. The forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 200 delegates and 20 company presentations by listed and private biotechnology companies seeking licensing & investment opportunities. Event's networking will be powered by our online one-to-one meeting system and dedicated meeting facilities to make the event more transactional and productive.

Hilton Zurich Airport Hotel
Zurich Switzerland

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Amsterdam Netherlands

3rd Edition of International Conference on Clinical Chemistry and Molecular Diagnostics April 19-20, 2018 Amsterdam, Netherlands Theme: "Recent developments and applications in Clinical Chemistry and Molecular Diagnostics" It includes prompt keynote presentations, Oral talks (Speaker Forum and Young research Forum), Poster presentations, Symposium, Workshops and Exhibitions.

London United Kingdom

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

London United Kingdom

Be able to decide on the best deal type – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tokyo, Japan
Tokyo Japan

Every year, globally Meetings International PTE, LTD organizes series of Biotechnology and Bioeconomy Meeting, Biotechnologists Meeting, to promote Knowledge, importance and challenges in recent innovations in Biotechnology and research field.The theme of the conference is ”Contemporary Challenges and profound innovative solutions for a sustainable Bio-world” which aims to address the challenges and solutions in the fields of Medical Biotechnology, Plant Biotechnology, Pharmaceutical Biotechnology, Agricultural Biotechnology, Genetic Engineering, Bioprocess Engineering.

Hyatt Centric Chicago Magnificent Mile Hotel
Chicago USA

Taking place on the first day of ASCO, the 4th Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

Brussels Belgium

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Brussels Belgium

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

London United Kingdom

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.